|0.4941||+0.0471||+10.54%||Vol 258.09K||1Y Perf -74.31%|
|Oct 4th, 2023 16:00 DELAYED|
|- -||-0.01 -1.94%|
|Target Price||9.17||Analyst Rating||Strong Buy 1.00|
|Potential %||1.76K||Finscreener Ranking||— -|
|Insiders Trans % 3/6/12 mo.||57/73/79||Value Ranking||★+ 43.80|
|Insiders Value % 3/6/12 mo.||79/87/89||Growth Ranking||— -|
|Insiders Shares Cnt. % 3/6/12 mo.||85/90/91||Income Ranking||— -|
|Price Range Ratio 52W %||4.64||Earnings Rating||—|
|Market Cap||63.44M||Earnings Date||6th Nov 2023|
Today's Price Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||6th Nov 2023|
|Estimated EPS Next Report||-0.10|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||333.95K|
|Avg. Monthly Volume||530.07K|
|Avg. Quarterly Volume||431.18K|
Clene Inc. (NASDAQ: CLNN) stock closed at 0.4941 per share at the end of the most recent trading day (a 10.54% change compared to the prior day closing price) with a volume of 258.09K shares and market capitalization of 63.44M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 74 people. Clene Inc. CEO is Robert Etherington.
The one-year performance of Clene Inc. stock is -74.31%, while year-to-date (YTD) performance is -50.59%. CLNN stock has a five-year performance of %. Its 52-week range is between 0.414 and 2.14, which gives CLNN stock a 52-week price range ratio of 4.64%
Clene Inc. currently has a PE ratio of -2.50, a price-to-book (PB) ratio of 114.28, a price-to-sale (PS) ratio of 321.23, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -49.94%, a ROC of -43.13% and a ROE of 1 085.74%. The company’s profit margin is -%, its EBITDA margin is -4 784.70%, and its revenue ttm is $239.00 Thousand , which makes it $0.00 revenue per share.
Of the last four earnings reports from Clene Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. Clene Inc.’s next earnings report date is 06th Nov 2023.
The consensus rating of Wall Street analysts for Clene Inc. is Strong Buy (1), with a target price of $9.17, which is +1 755.90% compared to the current price. The earnings rating for Clene Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Clene Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Clene Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 33.18, ATR14 : 0.06, CCI20 : -97.18, Chaikin Money Flow : -0.48, MACD : -0.06, Money Flow Index : 31.40, ROC : -17.22, RSI : 27.48, STOCH (14,3) : 14.61, STOCH RSI : 0.42, UO : 34.36, Williams %R : -85.39), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Clene Inc. in the last 12-months were: Alison Mosca (Buy at a value of $1 915 500), Etherington Robert Dee (Buy at a value of $20 250), John Henry Stevens (Buy at a value of $253 164), Jonathon Gay (Buy at a value of $84 500), Reed Neil Wilcox (Option Excercise at a value of $26 237), Robert Etherington (Buy at a value of $20 250), Stevens John Henry (Buy at a value of $253 164)
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.